Drawing for ADVAXIA BIOLOGICS

USPTO serial 79375943

ADVAXIA BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 7484103Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ADVAXIA BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Larry H. Tronco

Larry H. Tronco Holland & Hart, LLPPO Box 8749Trademark DocketingDenver, CO 80201

Goods and services

ClassDescriptionStatusFirst use
005VaccinesACTIVE—
042Scientific and technological services and research and design relating thereto, namely, scientific research, product design and development in the field of biotherapeutics, design and testing for new product development; industrial analysis services, namely, biotherapeutics manufacturing process development, material testing, product testing, product quality control testing and industrial research services in the field of biotherapeutics; design and development of computer hardware and software; biopharmaceutical product research and development for the pharmaceutical industry; research and development of vaccines and medicines; medical research; scientific research; scientific research in the pharmaceutical field; scientific research relating to bacteriology; scientific research relating to biologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 14, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 14, 2025FIMPFINAL DISPOSITION PROCESSED—
Jan 24, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 8, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 8, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 28, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 7, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 7, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2023RFNTREFUSAL PROCESSED BY IB—
Nov 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 16, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2023DOCKASSIGNED TO EXAMINER—
Aug 18, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 10, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance